基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 171.02
成立日期: 05/02/2001
 
分析
市值分佈:
87.19%
大市值
8.91%
中市值
3.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 251  
0%
 
100%
     10大 (49.74%)
代號 名稱 佔比% 持有日期
KALVKalVista Pharmaceuticals0.0528/02/2026
SVRASavara0.0528/02/2026
RIGLRigel Pharmaceuticals Inc0.0528/02/2026
CGEMCullinan Therapeutics0.0528/02/2026
AVBPArriVent BioPharma0.0528/02/2026
ICVX0.0531/01/2024
ZBIOZenas Biopharma Inc.0.0528/02/2026
PHATPhathom Pharmaceuticals0.0528/02/2026
PGENPrecigen0.0528/02/2026
SPRYARS Pharmaceuticals0.0528/02/2026
REPLReplimune Group0.0528/02/2026
ANROAlto Neuroscience0.0528/02/2026
BCAXBicara Therapeutics Inc.0.0528/02/2026
IRWDIronwood Pharmaceuticals0.0528/02/2026
ALTAltimmune0.0528/02/2026
CTKBCytek Biosciences0.0428/02/2026
RCKTRocket Pharmaceuticals0.0428/02/2026
ZVRAZevra Therapeutics0.0428/02/2026
CATXPerspective Therapeutics0.0428/02/2026
CMPSCOMPASS Pathways Plc0.0428/02/2026
  1    2    3    4    5    6    7    8   9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.